DGX Quest: רווח נקי למניה בארבעת הרבעונים האחרונים

The stability of the US domestic market ensures business predictability for Quest Diagnostics (DGX). The annual volatility of TTM net income per share captures this trend, with this metric equaling 17.70. Efficiency is driven by IT integration and network scale, although the reduction of government support and post-pandemic labor shortages are constraining profit dynamics.

Fundamental asset screening begins with an analysis of net income dynamics. The annual EPS TTM growth rate measures the percentage change in rolling earnings per share over a year, reflecting the efficiency of capital generation. Temporary dips in this indicator often signal modernization rather than stagnation. For Quest Diagnostics (DGX), such volatility is acceptable given the critical importance of its high-margin laboratory network to US healthcare.